Valeant bid for Allergan heats up, Pershing plans to replace Allergan board members
June 3rd 2014Allergan says it will “carefully review and consider” a revised proposal from Valeant of $53.8 billion bid-while Pershing Square, the hedge fund that owns 9.7 percent of Allergan is calling to replace the company’s board.
J&J, B+L, Essilor, others fined by Chinese authorities for price fixing
June 3rd 2014Chinese authorities fined Johnson & Johnson, Baush + Lomb, Essilor International, Nikon, and Carl Zeiss Vision Guangzhou a combined total of 19.6 million yuan, or $3 million, for price fixing in the country’s contact lens and eyeglasses market.
Omidria receives FDA approval for use in cataract surgery, IOL replacement
June 3rd 2014The U.S. Food and Drug Administration has approved Omeros’ phenylephrine and ketorolac injection, Omidria, for use during cataract surgery and intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis and to reduce postoperative pain.
New device aids early AMD diagnosis
May 31st 2014SECO International has a nearly 100-year history of providing optometric meetings of the highest caliber. SECO 2014 was no different. Lectures by our most esteemed colleagues were plentiful, and the knowledge base which was available to attendees was impactful. The exhibit hall provided the opportunity to demo many of the new technologies mentioned in the lectures. One such piece of equipment was AdaptDx by MacuLogix.
3 correction options for presbyopes
May 31st 2014The treatment choices presented to presbyopic patients will depend on many factors, including lifestyle, profession, general attitude toward vision, and levels of disposable income. The first step is ascertaining which two of the three visual acuities are most important to them: near, intermediate, or distance vision. For example, you probably wouldn't recommend a multifocal intraocular lens (IOL) to a professional airline pilot because those lenses may compromise nighttime distance vision.
MS medication may be associated with macula edema
May 31st 2014Gilenya (Fingolimod, Novartis), a sphingosine-1-phosphate receptor modulator, became the first FDA-approved oral agent for the treatment of relapsing forms of multiple sclerosis (MS) in September 2010.1 Recently, it has been associated with macular edema, referred to as FAME, or Fingolimod-associated macular edema.
7 tips for leaving a patient alone in the exam room
May 31st 2014When you leave a patient alone in a room, she is left to her own devices and is free to wreak havoc in your exam room if she so desires. Or look in places not meant for patients. You want your patient to be as comfortable as possible-but you want your exam room to remain intact.
Types of cataracts and their underlying conditions
May 31st 2014A cataract is a clouding of the crystalline lens, resulting in vision loss. There are different types of cataracts, and they may be associated with underlying conditions. Understanding the differences between types of cataracts will improve clinical management of your patients.
InDispensable: M&S Technologies adds stereo testing, Tommy Hilfiger launches True to Blue
May 31st 2014Santinelli International introduces new deblocking pliers, part of the company’s Visionary line of tools. Designed specifically for Nidek pliable blocks, the pliers feature a cushioned, silicone grip with built-in finger channels on the handle for comfort and ease of use.